Phase II trial of DS102 in chronic obstructive pulmonary disease (COPD) patients.
Phase of Trial: Phase II
Latest Information Update: 20 Oct 2017
At a glance
- Drugs DS 102 (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Proof of concept; Therapeutic Use
- 20 Oct 2017 According to an Afimmune media release, the company expects to initiate this trial soon and data read out is expected towards the end of 2018.
- 30 May 2016 New trial record
- 23 May 2016 According to DS Biopharma media release, the company will start this trial later this year.